Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Service

{
  "buyer": {
    "id": "GB-FTS-148208",
    "name": "NHS England North West (Greater Manchester)"
  },
  "date": "2025-05-16T14:10:51+01:00",
  "id": "022250-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-04ee22",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Manchester",
        "postalCode": "M1 3BN",
        "region": "UKD",
        "streetAddress": "3 Piccadilly Place, London Road"
      },
      "contactPoint": {
        "email": "necsu.psrprocurement@nhs.net"
      },
      "details": {
        "url": "https://www.england.nhs.uk/north-west/"
      },
      "id": "GB-FTS-148208",
      "identifier": {
        "legalName": "NHS England North West (Greater Manchester)",
        "noIdentifierRationale": "notOnAnyRegister"
      },
      "name": "NHS England North West (Greater Manchester)",
      "roles": [
        "buyer"
      ]
    }
  ],
  "tag": [
    "tenderUpdate"
  ],
  "tender": {
    "amendments": [
      {
        "id": "3",
        "unstructuredChanges": [
          {
            "newValue": {
              "text": "The aim of the NHS AAA Screening Programme is to reduce AAA-related mortality in service users who are eligible by detecting aneurysms at an early stage, ensuring appropriate surveillance and referral if required, and improving outcomes. This is through the provision of a systematic population-based screening programme for men and individuals assigned male gender at birth during the year, 1st April to 31st March, in which they turn 65 and, on request, for men over 65 years."
            },
            "oldValue": {
              "text": "INTENTION TO AWARD\nThe aim of the NHS AAA Screening Programme is to reduce AAA-related mortality in service users who are eligible by detecting aneurysms at an early stage, ensuring appropriate surveillance and referral if required, and improving outcomes. This is through the provision of a systematic population-based screening programme for men and individuals assigned male gender at birth during the year, 1st April to 31st March, in which they turn 65 and, on request, for men over 65 years.\nThe Relevant Authority intends to award contracts for the above Lots to existing providers under Direct Award C under the Health Care Services (Provider Selection Regime) Regulations 2023.\nThe Relevant Authority are undertaking a DAP C to award Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Services to the existing provider. The services will commence on 01 April 2025 with the contract concluding on 31 March 2028. The lifetime value of the contract is \u00a32,376,360.\nThis contract is divided into lots: No"
            },
            "where": {
              "label": "Short Description",
              "section": "II.1.4"
            }
          },
          {
            "newValue": {
              "date": "2025-03-13"
            },
            "oldValue": {
              "date": "1990-03-13"
            },
            "where": {
              "label": "Award of contract",
              "section": "V.2"
            }
          },
          {
            "newValue": {
              "text": "This is a Provider Selection Regime (PSR) contract award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nThis contract has been awarded.\nThe decision maker in this instance was Greater Manchester Screening Immunisation Contracting Commissioning and Finance Group for and on behalf of NHS England (Greater Manchester)\nThe key criteria was considered within the award criteria which was laid out in the procurement documents. The existing providers are satisfying the existing contracts and will likely satisfy the proposed new contracts. The providers have been assessed and passed against the relevant 5 key criteria and mandatory requirements.\nThere have been no conflicts of interest identified, and the COI process has complied with NHSE Policy in line with regulation 21.\nThe AAA service annual value after all 24-25 uplifts is \u00a3792,120.\nThe three year contract value would therefore be \u00a32,376,360."
            },
            "oldValue": {
              "text": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nThe publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by midnight 8 days following the publication of this transparency notice/ commencement of the standstill period - midnight on Thursday 27 March 2025 . This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\nThe decision maker in this instance was Greater Manchester Screening Immunisation Contracting Commissioning and Finance Group for and on behalf of NHS England (Greater Manchester)\nWritten representation should be sent to:\nNecsu.psrprocurement@nhs.net\nThe key criteria was considered within the award criteria which was laid out in the procurement documents. The existing providers are satisfying the existing contracts and will likely satisfy the proposed new contracts. The providers have been assessed and passed against the relevant 5 key criteria and mandatory requirements.\nThere have been no conflicts of interest identified, and the COI process has complied with NHSE Policy in line with regulation 21.\nThe AAA service annual value after all 24-25 uplifts is \u00a3792,120.\nThe three year contract value would therefore be \u00a32,376,360."
            },
            "where": {
              "label": "Additional information",
              "section": "VI.3"
            }
          }
        ]
      }
    ],
    "classification": {
      "description": "Health and social work services",
      "id": "85000000",
      "scheme": "CPV"
    },
    "description": "INTENTION TO AWARD\nThe aim of the NHS AAA Screening Programme is to reduce AAA-related mortality in service users who are eligible by detecting aneurysms at an early stage, ensuring appropriate surveillance and referral if required, and improving outcomes. This is through the provision of a systematic population-based screening programme for men and individuals assigned male gender at birth during the year, 1st April to 31st March, in which they turn 65 and, on request, for men over 65 years. \nThe Relevant Authority intends to award contracts for the above Lots to existing providers under Direct Award C under the Health Care Services (Provider Selection Regime) Regulations 2023.\nThe Relevant Authority are undertaking a DAP C to award Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Services to the existing provider.  The services will commence on 01 April 2025 with the contract concluding on 31 March 2028.  The lifetime value of the contract is \u00a32,376,360.\nThis contract is divided into lots: No",
    "id": "NHSE1016",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "mainProcurementCategory": "services",
    "title": "Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Service"
  }
}